BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 31, 2007
View Archived Issues
Amgen Spinout Relypsa Starts Business With $33M Series A
If the story of newly established Relypsa Inc., a company created to develop nonabsorbed polymeric drugs for renal and cardiovascular diseases, sounds more than a little familiar, that's probably because it is. (BioWorld Today)
Read More
India's Glenmark in $350M Deal With Lilly For Pain Compound
Read More
Acceleron Series C Gets $31M For Bone, Muscle Growth Bids
Read More
Genoptix IPO Soars 56 percent; RXi Files For Independence
Read More
Neurobiological Offering Nets $56 Million For Viprinex Trials
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Clinic Roundup
Read More